🎯 check Lonafarnib (SCH66336) product page
Lonafarnib (SCH66336) is a potent, multi-targeting farnesyltransferase inhibitor. It affects insulin/mTOR/Akt signaling pathways by blocking farnesylation and binding viral proteins, effectively inhibiting tumor growth, viral replication, and promoting apoptosis.